Lv11
10 积分 2024-04-18 加入
Abstract A020: CETSA profiling unveils novel targets engaged by anti-tumor drug rigosertib to inhibit RAS-MAPK signaling and trigger NLRP3 inflammasome activation
59分钟前
求助中
Cordycepin enhances anti-tumor immunity in colon cancer by inhibiting phagocytosis immune checkpoint CD47 expression
1年前
已完结
Cordycepin and kinase inhibition in cancer
1年前
已完结
Pharmacological and therapeutic potentials of cordycepin in hematological malignancies
1年前
已完结
皖公网安备34019202002308
